164 related articles for article (PubMed ID: 23863945)
1. Need for standardising adverse event reporting in testosterone trials.
Basaria S
Evid Based Med; 2014 Feb; 19(1):32-3. PubMed ID: 23863945
[No Abstract] [Full Text] [Related]
2. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
[TBL] [Abstract][Full Text] [Related]
3. Safety of testosterone replacement therapy.
Med Lett Drugs Ther; 2016 Mar; 58(1490):33-4. PubMed ID: 26963153
[No Abstract] [Full Text] [Related]
4. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.
Fernández-Balsells MM; Murad MH; Lane M; Lampropulos JF; Albuquerque F; Mullan RJ; Agrwal N; Elamin MB; Gallegos-Orozco JF; Wang AT; Erwin PJ; Bhasin S; Montori VM
J Clin Endocrinol Metab; 2010 Jun; 95(6):2560-75. PubMed ID: 20525906
[TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy and cardiovascular risk.
Walsh JP; Kitchens AC
Trends Cardiovasc Med; 2015 Apr; 25(3):250-7. PubMed ID: 25467243
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.
Anawalt BD
J Clin Endocrinol Metab; 2010 Jun; 95(6):2614-7. PubMed ID: 20525909
[No Abstract] [Full Text] [Related]
7. Effectiveness of testosterone therapy in obese men with low testosterone levels, for losing weight, controlling obesity complications, and preventing cardiovascular events: Protocol of a systematic review of randomized controlled trials.
Mangolim AS; Brito LAR; Nunes-Nogueira VS
Medicine (Baltimore); 2018 Apr; 97(17):e0482. PubMed ID: 29703008
[TBL] [Abstract][Full Text] [Related]
8. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
van der Poel HG
Eur Urol; 2009 Jul; 56(1):103-4. PubMed ID: 19282103
[No Abstract] [Full Text] [Related]
10. Update on the safety of testosterone therapy in cardiac disease.
Aaronson AJ; Morrissey RP; Nguyen CT; Willix R; Schwarz ER
Expert Opin Drug Saf; 2011 Sep; 10(5):697-704. PubMed ID: 21417959
[TBL] [Abstract][Full Text] [Related]
11. Testosterone therapy in women with androgen deficiency: Its time has come.
Guay A; Traish A
Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
[TBL] [Abstract][Full Text] [Related]
12. [Testosterone in old age: an up-date].
Hilbert-Walter A; Büttner R; Sieber C; Bollheimer C
Dtsch Med Wochenschr; 2012 Oct; 137(41):2117-22. PubMed ID: 23033170
[TBL] [Abstract][Full Text] [Related]
13. [Heart risk due to testosterone?].
Grätzel P
MMW Fortschr Med; 2015 Apr; 157(6):27. PubMed ID: 26015192
[No Abstract] [Full Text] [Related]
14. Androgens and cardiovascular disease.
Yeap BB
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular impact of testosterone therapy for hypogonadism.
Rastrelli G; Dicuio M; Reismann Y; Sforza A; Maggi M; Corona G
Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):617-625. PubMed ID: 30099911
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and sexual function.
Fugh-Berman A; Scialli AR
Curr Opin Urol; 2017 Nov; 27(6):516-518. PubMed ID: 28795961
[TBL] [Abstract][Full Text] [Related]
17. Controversy over Cardiovascular Risks of Testosterone Therapy.
Carter D
Am J Nurs; 2015 May; 115(5):17. PubMed ID: 25906216
[No Abstract] [Full Text] [Related]
18. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
Hassan J; Barkin J
Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
[TBL] [Abstract][Full Text] [Related]
19. In brief: testosterone and cardiovascular risk.
Med Lett Drugs Ther; 2014 Mar; 56(1437):17. PubMed ID: 24589496
[No Abstract] [Full Text] [Related]
20. Testosterone deficiency as a risk factor for cardiovascular disease.
Ullah MI; Washington T; Kazi M; Tamanna S; Koch CA
Horm Metab Res; 2011 Mar; 43(3):153-64. PubMed ID: 21283952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
